E-LIB Suche - Ergebnisse für: Vormoor, B.

1

S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC ..:

Minard-Colin, V. ; Buechner, J. ; Locatelli, F....
HemaSphere. 6 (2022) - p. 156-157 , 2022

Link: https://doi.org/10.1097/..

2

A phase I/II trial of AT9283, a selective inhibitor of auro..:

Vormoor, B. ; Veal, G. J. ; Griffin, M. J....
Pediatric Blood & Cancer. 64 (2016) 6 - p. e26351 , 2016

Link: https://doi.org/10.1002/..

3

417 Evaluating the activity of the p53-MDM2 inhibitor NDD00..:

Pecqueur, J. ; Vormoor, B. ; Zhao, Y..
European Journal of Cancer. 50 (2014) - p. 133 , 2014

Link: https://doi.org/10.1016/..

4

289 Assessment of a DNA-PK Inhibitor as a Chemo-potentiatin..:

O'Reilly, E. ; Vormoor, B. ; Kyle, S..
European Journal of Cancer. 48 (2012) - p. 88-89 , 2012

Link: https://doi.org/10.1016/..

5

349 Ewing's Sarcoma Cells Can Be Sensitized to Temozolomide..:

Vormoor, B. ; Wilkinson, S. ; Harvey, F...
European Journal of Cancer. 48 (2012) - p. 106-107 , 2012

Link: https://doi.org/10.1016/..

6

514 Sensitisation of paediatric solid tumours to DNA-damagi..:

Vormoor, B. ; Foy, K.E. ; Curtin, N..
European Journal of Cancer Supplements. 8 (2010) 7 - p. 164 , 2010

Link: https://doi.org/10.1016/..

7

S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC ..:

V. Minard-Colin ; J. Buechner ; F. Locatelli...
http://journals.lww.com/10.1097/01.HS9.0000843912.35755.7f. , 2022

Link: https://doi.org/10.1097/..

8

The MLL recombinome of acute leukemias in 2017:

Meyer, C ; Burmeister, T ; Gröger, D...
Leukemia. 32 (2017) 2 - p. 273-284 , 2017

Link: https://doi.org/10.1038/..

9

A reduced-intensity conditioning regimen for children with ..:

Strahm, B. ; Niemeyer, C.M. ; Vormoor, J....
Leukemia Research. 30 (2006) - p. S14 , 2006

Link: https://doi.org/10.1016/..

10

CD28 co-stimulation via tumour-specific chimaeric receptors..:

Altvater, B ; Pscherer, S ; Landmeier, S...
Clinical and Experimental Immunology. 144 (2006) 3 - p. 447-457 , 2006

Link: https://doi.org/10.1111/..

11

Characteristics and outcome of treatment-related MDS after ..:

Ammann, R. ; Zecca, M. ; Betts, D....
Leukemia Research. 30 (2006) - p. S19 , 2006

Link: https://doi.org/10.1016/..

12

High-Level Multilineage Engraftment of Human Cord Blood Cel..:

VORMOOR, J. ; LAPIDOT, T. ; PFLUMIO, F....
Journal of Hematotherapy. 2 (1993) 2 - p. 215-216 , 1993

Link: https://doi.org/10.1089/..

13

hiPSC-derived bone marrow milieu identifies a clinically ac..:

Pal, Deepali ; Blair, Helen J ; Parker, Jessica...
https://nrl.northumbria.ac.uk/id/eprint/49710/1/CR-MEDICINE-D-21-00480_R3.pdf. , 2022

Link: https://nrl.northumbria...

14

Implementation of paediatric precision oncology into clinic..:

Langenberg, Karin P.S ; Meister, Michael T ; Bakhuizen, Jette J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586161/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Implementation of paediatric precision oncology into clinic..:

Langenberg, Karin P.S ; Meister, Michael T ; Bakhuizen, Jette J...
0959-8049. , 2022

Link: https://dspace.library.u..